Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.
Tosco L, Laenen A, Briganti A, Gontero P, Karnes RJ, Albersen M, Bastian PJ, Chlosta P, Claessens F, Chun FK, Everaerts W, Gratzke C, Graefen M, Kneitz B, Marchioro G, Salas RS, Tombal B, Van den Broeck T, Moris L, Battaglia A, van der Poel H, Walz J, Bossi A, De Meerleer G, Haustermans K, Van Poppel H, Spahn M, Joniau S. Tosco L, et al. Among authors: chun fk. Prostate Cancer Prostatic Dis. 2017 Dec;20(4):407-412. doi: 10.1038/pcan.2017.29. Epub 2017 May 9. Prostate Cancer Prostatic Dis. 2017. PMID: 28485390
Molecular cancer phenotype in normal prostate tissue.
Schlomm T, Hellwinkel OJ, Buness A, Ruschhaupt M, Lübke AM, Chun FK, Simon R, Budäus L, Erbersdobler A, Graefen M, Huland H, Poustka A, Sültmann H. Schlomm T, et al. Among authors: chun fk. Eur Urol. 2009 Apr;55(4):885-90. doi: 10.1016/j.eururo.2008.04.105. Epub 2008 May 16. Eur Urol. 2009. PMID: 18501497
Is node-positive prostate cancer always a systemic disease?
Briganti A, Chun FK, Karakiewicz PI, Rigatti P, Montorsi F. Briganti A, et al. Among authors: chun fk. Eur Urol. 2008 Aug;54(2):243-6. doi: 10.1016/j.eururo.2008.05.026. Epub 2008 May 22. Eur Urol. 2008. PMID: 18511184 No abstract available.
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
Lughezzani G, Budäus L, Isbarn H, Sun M, Perrotte P, Haese A, Chun FK, Schlomm T, Steuber T, Heinzer H, Huland H, Montorsi F, Graefen M, Karakiewicz PI. Lughezzani G, et al. Among authors: chun fk. Eur Urol. 2010 Apr;57(4):562-8. doi: 10.1016/j.eururo.2009.12.003. Epub 2009 Dec 10. Eur Urol. 2010. PMID: 20018437
Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
Schmitges J, Karakiewicz PI, Sun M, Abdollah F, Budäus L, Isbarn H, Bianchi M, Trinh QD, Schlomm T, Chun FK, Graefen M, Steuber T. Schmitges J, et al. Among authors: chun fk. Eur J Surg Oncol. 2012 Jul;38(7):624-9. doi: 10.1016/j.ejso.2012.04.005. Epub 2012 Apr 22. Eur J Surg Oncol. 2012. PMID: 22531769
Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy.
Gandaglia G, Suardi N, Gallina A, Abdollah F, Capitanio U, Salonia A, Colombo R, Bianchi M, Chun FK, Hansen J, Rigatti P, Montorsi F, Briganti A. Gandaglia G, et al. Among authors: chun fk. J Sex Med. 2012 Aug;9(8):2187-94. doi: 10.1111/j.1743-6109.2012.02812.x. Epub 2012 Jun 27. J Sex Med. 2012. PMID: 22738395
Initial prostate biopsy: development and internal validation of a biopsy-specific nomogram based on the prostate cancer antigen 3 assay.
Hansen J, Auprich M, Ahyai SA, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Fisch M, Abbou CC, Schalken JA, Fradet Y, Marks LS, Ellis W, Partin AW, Pummer K, Graefen M, Haese A, Walz J, Briganti A, Shariat SF, Chun FK. Hansen J, et al. Among authors: chun fk. Eur Urol. 2013 Feb;63(2):201-9. doi: 10.1016/j.eururo.2012.07.030. Epub 2012 Jul 20. Eur Urol. 2013. PMID: 22854248
534 results